Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:8 Issue:2 Number:107 ISSN#:2564-2537
Author Verified
ACE Report #10431
Ace Report Cover Arthroplasty

NSAIDs associated with reduction in heterotopic ossification development versus placebo in THA

How to Cite

OrthoEvidence. NSAIDs associated with reduction in heterotopic ossification development versus placebo in THA. ACE Report. 2019;8(2):107. Available from: https://myorthoevidence.com/AceReport/Report/10431

Study Type:Meta-analysis/Systematic Review
OE Level Evidence:1
Journal Level of Evidence:N/A

Non-steroidal anti-inflammatory drugs for heterotopic ossification prophylaxis after total hip arthroplasty

Bone Joint J. 2018 Jul;100-B(7):915-922. doi: 10.1302/0301-620X.100B7.BJJ-2017-1467.R1

Contributing Authors: DF Amanatullah M Joice GI Vasileiadis

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here



29 randomized controlled trials were selected for inclusion in this meta-analysis which compared the rates of heterotopic ossification after total hip arthroplasty between groups of patients treated with selective non-steroidal anti-inflammatory drugs (NSAIDs), groups treated with non-selective NSAIDS, and groups treated with placebo. Compared to placebo, both selective and non-selective NSAID gro...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.